Follow
Alyssa Kosmides Galaro
Alyssa Kosmides Galaro
Food and Drug Administration
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation
RA Meyer, JC Sunshine, K Perica, AK Kosmides, K Aje, JP Schneck, ...
Small (Weinheim an der Bergstrasse, Germany) 11 (13), 1519, 2015
1782015
Metabolomic fingerprinting: challenges and opportunities
AK Kosmides, K Kamisoglu, SE Calvano, SA Corbett, I Androulakis
Critical Reviews™ in Biomedical Engineering 41 (3), 2013
1762013
Dual targeting nanoparticle stimulates the immune system to inhibit tumor growth
AK Kosmides, JW Sidhom, A Fraser, CA Bessell, JP Schneck
ACS nano 11 (6), 5417-5429, 2017
1452017
Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma
AK Kosmides, RA Meyer, JW Hickey, K Aje, KN Cheung, JJ Green, ...
Biomaterials 118, 16-26, 2017
1052017
Separating T cell targeting components onto magnetically clustered nanoparticles boosts activation
AK Kosmides, K Necochea, JW Hickey, JP Schneck
Nano letters 18 (3), 1916-1924, 2018
602018
Linking form to function: Biophysical aspects of artificial antigen presenting cell design
K Perica, AK Kosmides, JP Schneck
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (4), 781-790, 2015
522015
ImmunoMap: a bioinformatics tool for T-cell repertoire analysis
JW Sidhom, CA Bessell, JJ Havel, A Kosmides, TA Chan, JP Schneck
Cancer immunology research 6 (2), 151-162, 2018
412018
Engineering platforms for t cell modulation
JW Hickey, AK Kosmides, JP Schneck
International Review of Cell and Molecular Biology 341, 277-362, 2018
152018
Pulsatile glucocorticoid secretion: origins and downstream effects
JD Scheff, AK Kosmides, SE Calvano, SF Lowry, IP Androulakis
IEEE transactions on biomedical engineering 58 (12), 3504-3507, 2011
152011
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...
Journal for immunotherapy of cancer 4, 1-106, 2016
102016
ImmunoMap: a bioinformatics tool for T-cell repertoire analysis. Cancer Immunol. Res. 2018; 6: 151–162. doi: 10.1158/2326-6066
JW Sidhom, CA Bessell, JJ Havel, A Kosmides, TA Chan, JP Schneck
CIR-17-0114.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
8
Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
AK Kosmides, J Schneck
Journal for ImmunoTherapy of Cancer 2 (Suppl 3), P108, 2014
22014
Immunoswitch nanoparticles for reprogrammed t cell responses
AK Kosmides, JP Schenck
US Patent App. 16/327,508, 2019
12019
Biomimicry of the Antigen Presenting Cell: The Importance of Size and Shape
R Meyer, A Kosmides, JP Schneck, JJ Green
TISSUE ENGINEERING PART A 22, S39-S39, 2016
12016
Production of antigen-specific t-cells
M Oelke, JL Santos, S Kim, J Schneck, A Kosmides
US Patent App. 18/111,975, 2023
2023
Production of antigen-specific t-cells
M Oelke, JL Santos, S Kim, J Schneck, A Kosmides
US Patent App. 16/084,121, 2020
2020
PRODUCTION OF T CELLS SPECIFIC TO ANTIGENS
M Oelke, JL SANTOS, S Kim, J Schneck, A KOSMIDES
2019
Utilizing nanotechnology to improve the activation of CD8 T cells for cancer immunotherapy
AK Kosmides
Johns Hopkins University, 2018
2018
Immunoswitch particles target activation of anti-tumor CD8+ T cells to inhibit tumor growth
A Kosmides, JW Sidhom, A Fraser, C Bessell, J Schneck
JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017
2017
Production of antigen-specific t-cells
M Oelke, JL Santos, S Kim, J Schneck, A KOSMIDES
2017
The system can't perform the operation now. Try again later.
Articles 1–20